The International Headache Society classification and Diagnostic Criteria are Valid and Extremely Useful

Cephalalgia ◽  
1996 ◽  
Vol 16 (5) ◽  
pp. 294-295 ◽  
Author(s):  
J Olesen
Keyword(s):  
Diagnostic Criteria ◽  
International Headache Society ◽  
International Headache Society Classification

Application of the International Headache Society Classification Criteria in 652 Cluster Headache Patients

Cephalalgia ◽  
2001 ◽  
Vol 21 (2) ◽  
pp. 145-150 ◽  
Author(s):  
P Torelli ◽  
D Cologno ◽  
C Cademartiri ◽  
GC Manzoni
Keyword(s):  
Cluster Headache ◽  
Diagnostic Criteria ◽  
International Headache Society ◽  
Total Sample ◽  
Classification Criteria ◽  
Coding System ◽  
Pain Location ◽  
Ihs Classification ◽  
Study Population ◽  
International Headache Society Classification

We applied the International Headache Society (IHS) classification coding parameters to a study population of 652 cluster headache (CH) patients, in order to determine how many patients did not fulfil the diagnostic criteria for group 3.1 and to find out any diagnostic elements that could be changed in the upcoming revision of the classification to make it more relevant to current clinical practice. Ninety-nine patients were found to have cluster-like disorder (3.3), including 74 (74.7%) who did not fulfil the diagnostic criteria for CH, because either pain was not associated with any of the accompanying autonomic phenomena listed in the classification or it was not located orbitally, supraorbitally and/or temporally. A review of our total sample showed that 72.0% of patients reported frontal and occipital pain location; in 61.8%, 33.4% and 39.1% of cases, attacks were also accompanied by restlessness/agitation, nausea and photophobia, respectively. In a coding system that took into account the diagnostic elements that we considered in our study, group 3.1 of the existing IHS classification would actually include 51 of the 99 patients currently coded as 3.3.

Chronic Paroxysmal Hemicrania in a Patient with a Macroprolactinoma

Cephalalgia ◽  
2006 ◽  
Vol 26 (6) ◽  
pp. 738-741 ◽  
Author(s):  
M Sarov ◽  
D Valade ◽  
C Jublanc ◽  
A Ducros
Keyword(s):  
International Headache Society ◽  
Paroxysmal Hemicrania ◽  
Chronic Paroxysmal Hemicrania ◽  
International Headache Society Classification

We report a patient with headaches meeting the criteria of chronic paroxysmal hemicrania, as defined by the International Headache Society classification. Headaches were fully responsive to indomethacin during the first 3 months of treatment but recurred when daily doses were lowered. Investigations revealed a macroprolactinoma. Headaches stopped after cabergoline treatment. This report further suggests that patients with paroxysmal hemicrania should be investigated for pituitary abnormalities.

A Population-Based Analysis of the Diagnostic Criteria of the International Headache Society

Cephalalgia ◽  
1991 ◽  
Vol 11 (3) ◽  
pp. 129-134 ◽  
Author(s):  
Birthe Krogh Rasmussen ◽  
Rigmor Jensen ◽  
Jes Olesen
Keyword(s):  
Physical Activity ◽  
Diagnostic Criteria ◽  
International Headache Society ◽  
Normal Subjects ◽  
Population Based ◽  
Tension Type Headache ◽  
Headache Disorders ◽  
Specific Proposal ◽  
Accompanying Symptoms ◽  
Type Headache

In 740 representative normal subjects a diagnostic headache interview and a neurological examination provided the necessary information to classify headache disorders according to the operational diagnostic criteria of the International Headache Society (IHS). Sixteen per cent (n = 119) had migraine, 78% (n = 578) tension-type headache. In migraineurs, pain was of a pulsating quality in 78%, severe in 85%, unilateral in 62%, and aggravated by routine physical activity in 96%. Tension-type headache was of a pressing quality in 78%, mild or moderate in 99%, bilateral in 90%, and 72% had no aggravation by physical activity. The accompanying symptoms of nausea, photo- and phonophobia occurred frequently and were usually moderate or severe in migraine subjects, and if present in subjects with tension-type headache, they were usually mild. Only two subjects had unclassifiable headache. The IHS Classification is thus exhaustive. The criteria may be improved by mandatory demands to the criterion of pain intensity leaving other features of pain as supportive for the diagnosis and by including graded severity of accompanying symptoms. A specific proposal is given.

Triptans in Orgasmic Headache

Cephalalgia ◽  
2006 ◽  
Vol 26 (12) ◽  
pp. 1458-1461 ◽  
Author(s):  
A Frese ◽  
A Gantenbein ◽  
M Marziniak ◽  
IW Husstedt ◽  
PJ Goadsby ◽  
...  
Keyword(s):  
Sexual Activity ◽  
Positive Response ◽  
Therapeutic Option ◽  
International Headache Society ◽  
Severe Headache ◽  
Activity Type ◽  
Short Term ◽  
International Headache Society Classification ◽  
Short Term Prophylaxis

Orgasmic headache (headache associated with sexual activity type 2 according to the International Headache Society classification) is a sudden severe headache which occurs at orgasm. Experiences with triptan therapy are described. Two out of four patients with severe headache continuing for >2 h had a positive response to acute triptan therapy. Two out of three patients using triptans as short-term prophylaxis reported a reliable response on several occasions. Trip- tans might be a treatment option to shorten orgasmic headache attacks after the diagnosis is clear and, particularly, subarachnoid haemorrhage has been excluded. In patients who chose to predict their sexual activity, short-term prophylaxis with oral triptans 30 min before sexual activity might be a therapeutic option in those not responsive to or not tolerating indomethacin.

Clinical characteristics and therapeutic options in hypnic headache

Cephalalgia ◽  
2010 ◽  
Vol 30 (12) ◽  
pp. 1435-1442 ◽  
Author(s):  
Dagny Holle ◽  
Steffen Naegel ◽  
Sarah Krebs ◽  
Zaza Katsarava ◽  
Hans-Christoph Diener ◽  
...  
Keyword(s):  
Side Effects ◽  
Effective Treatment ◽  
Diagnostic Criteria ◽  
Clinical Characteristics ◽  
Motor Behavior ◽  
International Headache Society ◽  
Treatment Options ◽  
Therapeutic Options ◽  
Individual Treatment ◽  
Hypnic Headache

Background: Hypnic headache (HH) is a rare primary headache disorder that is characterized by exclusively sleep-related headache attacks. Because of its low prevalence, clinical features and therapeutic options are widely unknown or under discussion. Methods: Twenty patients with HH were examined and interviewed using a standardized questionnaire in regard to their clinical characteristics and effective treatment regimens. Data were evaluated according to current International Headache Society (IHS) diagnostic criteria. Individual treatment history and effective treatment options were compared with expected efficacy based on current literature. Results: In conflict to current IHS criteria, 15% of patients reported trigemino-autonomic symptoms. All patients showed distinct motor behavior during their headache attacks. In acute pain attacks caffeine was most effective. Lithium, topiramate, melatonin, amitriptyline and indomethacin were sometimes useful prophylactic treatment options but were often associated with side effects. Conclusions: Our results underline the need for modification of the IHS diagnostic criteria of HH to better reflect the actual clinical characteristics of this headache. Caffeine should be considered as first-line acute therapy. Prophylactic medical treatment should be carefully evaluated in regard to side effects in this aged patient population, as this seems to be a major concern of patients apart from pure pain reduction.

Migraine and Left-Handedness are not Associated. A New Case—Control Study and Meta-Analysis

Cephalalgia ◽  
2008 ◽  
Vol 28 (5) ◽  
pp. 553-557 ◽  
Author(s):  
K Biehl ◽  
A Frese ◽  
M Marziniak ◽  
I-W Husstedt ◽  
S Evers
Keyword(s):  
Diagnostic Criteria ◽  
Case Control Study ◽  
Matched Control ◽  
International Headache Society ◽  
Meta Analysis ◽  
Case Control ◽  
Left Handedness ◽  
Significant Difference ◽  
Control Study ◽  
Age And Sex

To investigate the possible association between migraine and left-handedness, we enrolled 100 patients with a diagnosis of migraine according to the International Headache Society diagnostic criteria and 100 age- and sex-matched control subjects into a case—control study. Handedness was determined by the Edinburgh Handedness Inventory. There was no significant difference in the frequency or grade of left-handedness between the two groups. Additionally, we pooled our data with those from five similar studies, which did not alter the result. Thus, neither our study nor the meta-analysis support Geschwind and Behan's hypothesis of an association between migraine and left-handedness.

scholarly journals Migraine and Vertigo

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Mehmet Karatas
Keyword(s):  
International Headache Society ◽  
Age Groups ◽  
Epidemiologic Studies ◽  
Migrainous Vertigo ◽  
Acute Attacks ◽  
Cacna1a Gene ◽  
International Headache Society Classification ◽  
Cerebellar Symptoms ◽  
Paroxysmal Positional Vertigo

Migraine and vertigo are common disorders in medicine, affecting about 14–16% and 7–10%, respectively, of the general population. Recent epidemiologic studies indicate that 3.2% of the population have both migraine and vertigo. Vertigo may occur in up to 25% of patients with migraine. Migraine is the most frequent vascular disorder causing vertigo in all age groups. Migraine leads to various central or peripheral vestibular syndromes with vertigo such as migrainous vertigo, basilar-type migraine, benign paroxysmal vertigo of childhood, and other vertigo syndromes related to migraine. Migrainous vertigo is the most common cause of spontaneous recurrent vertigo. Diagnostic criteria for migrainous vertigo have been proposed but are not included in the most recent International Headache Society classification of migraine. On the other hand, there are statistical associations between migraine and vertigo syndromes including benign paroxysmal positional vertigo, Meniere's disease, persistent cerebellar symptoms, anxiety-related dizziness, and motion sickness. Vertigo can also act as a migraine trigger. Although some mutations in the CACNA1A gene have been identified in some familial cases, the mechanism of migraine-associated vertigo is still obscure. Treatment includes vestibular suppressants for acute attacks and migraine prophylaxis for patients with frequent attacks.

Sign in / Sign up

Export Citation Format

Share Document